We are proud to announce the selection of Dr. Reshma Ramracheya for an oral presentation at the prestigious Third European Association for the Study of Diabetes Incretin Study Group Meeting. Our Head of Pharmaceutical Operations will be discussing what is “known, new, controversial” in the incretin field so as to identify key questions that need to be addressed in clinical and fundamental science and propose key clinical trials.

Latest News
  • 03 July 2020 Nutricosmetics clinical trials: CIDP provides the science and data to support a product’s touted properties!
  • 26 June 2020 CIDP Brazil Reopening - Health and Safety first!
  • 12 June 2020 Upcoming webinar on Claims & Efficacy Substantiation by Bandana Seesurn, Managing Director of CIDP Singapore
Archives

Time Zone

Choose a centre